<DOC>
	<DOCNO>NCT02063100</DOCNO>
	<brief_summary>-Evaluate efficacy safety Shenyankangfu Tablets control proteinuria patient primary glomerulonephritis compare Losartan potassium .</brief_summary>
	<brief_title>Efficacy Safety Shenyankangfu Tablets Primary Glomerulonephritis</brief_title>
	<detailed_description />
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Inclusion Diagnosed primary glomerulonephritis Aged 18 70 years，male female Blood pressure control ≤140/90mmHg GFR≥45ml/min/1.73㎡ 0.5g≤24 hour proteinuria≤3.0g Traditional Chinese medicine syndrome conform QiYin Deficiency Obtain agreement patient guardian , sign informed consent file secondary nephropathy Take glucocorticoid , immunosuppressant Tripterygium drug last 12 month Take Chinese patent medicine decoction reduce proteinuria last 2 week Take reninangiotensin system blocker last 4 week Combined severe primary disease heart , brain , liver hematopoietic system , serious disease affect patient 's life Pregnant lactate woman Allergic predisposition know allergic drug composition Blood presser ＜90/60mmHg With unilateral bilateral renal artery stenosis With mental disorder poor compliance Be suspect confirm alcohol , drug abuse history Be participate another clinical study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Glomerulonephritis</keyword>
	<keyword>proteinuria</keyword>
	<keyword>shenyankangfu tablet</keyword>
	<keyword>Losartan Potassium</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>